RMX-VH-GBM

N/A

Report date: 2024/07/30 17:49:25

NME

Base Information

Drug NameRMX-VH-GBM

Drug Alias NameRMX-VH-GBM

ClassificationSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)

Mechanisms of ActionEmission-computed tomography enhancersIonising radiation emittersPositron-emission tomography enhancers

TargetsNot applicable

Therapy Area/IndicationsGlioblastoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesRadiomedix Inc

China Registration ClassN/A

Active CompaniesRadiomedix Inc

Inactive CompaniesN/A

Active IndicationsGlioblastoma

Inactive IndicationsN/A

ATC CodeN/A